Cargando…
Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network
Cancer is a life-threatening disease, but cancer therapies based on epigenetic mechanisms have made great progress. Enhancer of zeste homolog 2 (EZH2) is the key catalytic component of Polycomb repressive complex 2 (PRC2) that mediates the tri-methylation of lysine 27 on histone 3 (H3K27me3), a well...
Autores principales: | Hao, Aixin, Wang, Yunxuan, Stovall, Daniel B., Wang, Yu, Sui, Guangchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416728/ https://www.ncbi.nlm.nih.gov/pubmed/34512145 http://dx.doi.org/10.7150/ijbs.63488 |
Ejemplares similares
-
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)
por: Li, Sui, et al.
Publicado: (2022) -
Emerging roles of lncRNAs in the post-transcriptional regulation in cancer
por: He, Rong-Zhang, et al.
Publicado: (2019) -
The Emerging Role of lncRNAs in Spinal Cord Injury
por: Wang, Fei, et al.
Publicado: (2019) -
Emerging role of lncRNAs in osteoarthritis: An updated review
por: Wang, Rongliang, et al.
Publicado: (2022) -
lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
por: Wozniak, Michal, et al.
Publicado: (2023)